INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $159 | -97.8% | 758 | -98.3% | 0.00% | – |
Q1 2023 | $7,222 | -37.7% | 45,136 | +116.3% | 0.00% | – |
Q4 2022 | $11,583 | -88.2% | 20,872 | -74.6% | 0.00% | – |
Q3 2022 | $98,000 | +48.5% | 82,150 | -21.7% | 0.00% | – |
Q2 2022 | $66,000 | +1000.0% | 104,961 | +1898.5% | 0.00% | – |
Q1 2022 | $6,000 | -88.7% | 5,252 | -77.7% | 0.00% | – |
Q4 2021 | $53,000 | +82.8% | 23,595 | +178.3% | 0.00% | – |
Q3 2021 | $29,000 | -61.3% | 8,478 | -66.0% | 0.00% | – |
Q2 2021 | $75,000 | +31.6% | 24,958 | +41.6% | 0.00% | – |
Q1 2021 | $57,000 | +2750.0% | 17,622 | +1502.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 1,100 | -52.5% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 2,316 | +10.3% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 2,100 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 2,100 | -0.2% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 2,104 | +8.6% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 1,938 | +29.2% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
Q1 2019 | $3,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | -66.7% | 1,500 | -30.3% | 0.00% | – |
Q3 2018 | $6,000 | +100.0% | 2,151 | +39.5% | 0.00% | – |
Q2 2018 | $3,000 | -57.1% | 1,542 | -51.9% | 0.00% | – |
Q1 2018 | $7,000 | -53.3% | 3,203 | -55.3% | 0.00% | – |
Q4 2017 | $15,000 | +7.1% | 7,169 | -33.4% | 0.00% | – |
Q3 2017 | $14,000 | -48.1% | 10,759 | -38.6% | 0.00% | – |
Q2 2017 | $27,000 | -6.9% | 17,525 | +93.7% | 0.00% | – |
Q1 2017 | $29,000 | -75.0% | 9,047 | -89.5% | 0.00% | – |
Q4 2016 | $116,000 | -8.7% | 86,306 | +6.0% | 0.00% | – |
Q3 2016 | $127,000 | +353.6% | 81,430 | +285.0% | 0.00% | – |
Q2 2016 | $28,000 | +7.7% | 21,150 | +316.5% | 0.00% | – |
Q1 2016 | $26,000 | -64.4% | 5,078 | -45.7% | 0.00% | – |
Q4 2015 | $73,000 | +160.7% | 9,353 | +178.8% | 0.00% | – |
Q3 2015 | $28,000 | -96.6% | 3,355 | -95.5% | 0.00% | – |
Q2 2015 | $825,000 | +137.1% | 75,306 | +202.3% | 0.00% | – |
Q1 2015 | $348,000 | -58.6% | 24,911 | -50.0% | 0.00% | – |
Q4 2014 | $841,000 | +106.6% | 49,797 | +64.0% | 0.00% | – |
Q3 2014 | $407,000 | +68.9% | 30,357 | +60.2% | 0.00% | – |
Q2 2014 | $241,000 | +58.6% | 18,949 | +48.6% | 0.00% | – |
Q1 2014 | $152,000 | -72.9% | 12,749 | -68.6% | 0.00% | – |
Q4 2013 | $561,000 | +13.3% | 40,592 | +42.9% | 0.00% | – |
Q3 2013 | $495,000 | -61.6% | 28,414 | -64.3% | 0.00% | – |
Q2 2013 | $1,289,000 | – | 79,640 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
Bleichroeder LP | 250,000 | $158,000 | 0.03% |
Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
Ergoteles LLC | 419,652 | $265,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |